New drug shows promise against multiple Hard-to-Treat cancers
NCT ID NCT04482309
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 19 times
Summary
This study tests a drug called trastuzumab deruxtecan (T-DXd) in people with several types of advanced cancers that have a specific protein called HER2. The goal is to see if the drug can shrink tumors and control the disease. About 477 participants with cancers like bladder, cervical, ovarian, and rare tumors will receive the drug and be monitored for response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PART 1: BLADDER, BILIARY TRACT, CERVICAL, ENDOMETRIAL, OVARIAN, PANCREATIC CANCER, RARE TUMORS, ANY TUMOR TYPE EXCLUDING BREAST, GASTRIC, COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Santa Rosa, California, 95403, United States
-
Research Site
Chicago, Illinois, 60637, United States
-
Research Site
Muncie, Indiana, 47303, United States
-
Research Site
Boston, Massachusetts, 02215, United States
-
Research Site
Middletown, New Jersey, 07748, United States
-
Research Site
Harrison, New York, 10604, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
New York, New York, 10065, United States
-
Research Site
Durham, North Carolina, 27710, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Seattle, Washington, 98195, United States
-
Research Site
Auchenflower, 4066, Australia
-
Research Site
Blacktown, 2148, Australia
-
Research Site
Camperdown, 2050, Australia
-
Research Site
Heidelberg, 3084, Australia
-
Research Site
Melbourne, 3000, Australia
-
Research Site
Nedlands, 6009, Australia
-
Research Site
Brussels, 1090, Belgium
-
Research Site
Leuven, 3000, Belgium
-
Research Site
Liège, 4000, Belgium
-
Research Site
Porto Alegre, 90035-000, Brazil
-
Research Site
São Paulo, 01246-000, Brazil
-
Research Site
Vitória, 29043-272, Brazil
-
Research Site
Kelowna, British Columbia, V1Y 5L3, Canada
-
Research Site
Ottawa, Ontario, K1H 8L6, Canada
-
Research Site
Québec, Quebec, G1J 1Z4, Canada
-
Research Site
Montreal, H3T 1E2, Canada
-
Research Site
Brno, 656 53, Czechia
-
Research Site
Hradec Králové, 500 05, Czechia
-
Research Site
Olomouc, 77900, Czechia
-
Research Site
Prague, 150 06, Czechia
-
Research Site
Prague, 180 81, Czechia
-
Research Site
Delhi, 110085, India
-
Research Site
Gurgaon, 122001, India
-
Research Site
Kolkata, 700160, India
-
Research Site
Mumbai, 400012, India
-
Research Site
Milan, 20162, Italy
-
Research Site
Milan, 20141, Italy
-
Research Site
Naples, 80131, Italy
-
Research Site
Rome, 168, Italy
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Kashiwa, 277-8577, Japan
-
Research Site
Suita-shi, 565-0871, Japan
-
Research Site
Amsterdam, 1066CX, Netherlands
-
Research Site
Delft, 2625 AD, Netherlands
-
Research Site
Groningen, 9700, Netherlands
-
Research Site
Bydgoszcz, 85-796, Poland
-
Research Site
Gdansk, 80-952, Poland
-
Research Site
Krakow, 31-501, Poland
-
Research Site
Poznan, 60-355, Poland
-
Research Site
Warsaw, 02-781, Poland
-
Research Site
Kaluga, 248007, Russia
-
Research Site
Moscow, 115419, Russia
-
Research Site
Moscow, 115478, Russia
-
Research Site
Moscow, 117997, Russia
-
Research Site
Moscow, 121205, Russia
-
Research Site
Moscow, 143423, Russia
-
Research Site
Moscow, 143442, Russia
-
Research Site
Saint Petersburg, 195271, Russia
-
Research Site
Saint Petersburg, 197758, Russia
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Seoul, 5505, South Korea
-
Research Site
Barcelona, 8035, Spain
-
Research Site
Córdoba, 14004, Spain
-
Research Site
Madrid, 28027, Spain
-
Research Site
Madrid, 28040, Spain
-
Research Site
Madrid, 28041, Spain
-
Research Site
Madrid, 28046, Spain
-
Research Site
Valencia, 46014, Spain
-
Research Site
Taichung, 40705, Taiwan
-
Research Site
Tainan, 736, Taiwan
-
Research Site
Taipei, 100, Taiwan
-
Research Site
Taipei, 10449, Taiwan
-
Research Site
Taipei, 11217, Taiwan
-
Research Site
Taoyuan, 333, Taiwan
-
Research Site
Bangkok, 10210, Thailand
-
Research Site
Bangkok, 10330, Thailand
-
Research Site
Bangkok, 10400, Thailand
-
Research Site
Chiang Mai, 50200, Thailand
-
Research Site
Hat Yai, 90110, Thailand
-
Research Site
Khon Kaen, 40002, Thailand
-
Research Site
Muang, 50200, Thailand
-
Research Site
Ongkharak, 26120, Thailand
-
Research Site
London, SW2 6JJ, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
-
Research Site
Sutton, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.